USANA Health Sciences Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Jim Brown
Chief executive officer
US$1.8m
Total compensation
CEO salary percentage | 34.8% |
CEO tenure | 7.3yrs |
CEO ownership | n/a |
Management average tenure | 7.1yrs |
Board average tenure | 6yrs |
Recent management updates
Recent updates
USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27USANA Earnings Preview: From China's Challenge To India's Promise
Jul 21USANA Health Sciences says Brown will transition to CEO in July 2023
Feb 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Feb 02USANA Health Sciences down 17% after revising 2022 outlook below consensus estimates
Oct 25Here's What To Make Of USANA Health Sciences' (NYSE:USNA) Decelerating Rates Of Return
Oct 18Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 26%?
Jul 22Returns On Capital At USANA Health Sciences (NYSE:USNA) Have Stalled
Jul 07Is USANA Health Sciences (NYSE:USNA) Using Too Much Debt?
Jun 14Is USANA Health Sciences, Inc. (NYSE:USNA) Potentially Undervalued?
May 31USANA: Soft Quarter, Bottomed Out Stock, 9.8x Ex-Cash P/E, 65% Upside
Apr 28Capital Investments At USANA Health Sciences (NYSE:USNA) Point To A Promising Future
Mar 05USANA: 15x P/E, 14% Net Cash, Stock Repurchases
Feb 17A Look At The Intrinsic Value Of USANA Health Sciences, Inc. (NYSE:USNA)
Jan 24At US$99.77, Is It Time To Put USANA Health Sciences, Inc. (NYSE:USNA) On Your Watch List?
Jan 11Here's Why I Think USANA Health Sciences (NYSE:USNA) Might Deserve Your Attention Today
Nov 15USANA: Q3 Mixed Results, We See 35% Upside, 15% 10-Year EPS CAGR
Oct 28USANA: +42% EPS Growth, Upside Of 37%, Rapidly Growing In China Markets
Sep 29Is Now An Opportune Moment To Examine USANA Health Sciences, Inc. (NYSE:USNA)?
Sep 28CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Dec 30 2023 | n/a | n/a | US$64m |
Sep 30 2023 | n/a | n/a | US$60m |
Jul 01 2023 | n/a | n/a | US$63m |
Apr 01 2023 | n/a | n/a | US$65m |
Dec 31 2022 | US$2m | US$624k | US$69m |
Oct 01 2022 | n/a | n/a | US$77m |
Jul 02 2022 | n/a | n/a | US$89m |
Apr 02 2022 | n/a | n/a | US$108m |
Jan 01 2022 | US$2m | US$600k | US$117m |
Oct 02 2021 | n/a | n/a | US$136m |
Jul 03 2021 | n/a | n/a | US$139m |
Apr 03 2021 | n/a | n/a | US$129m |
Jan 02 2021 | US$2m | US$599k | US$125m |
Sep 26 2020 | n/a | n/a | US$116m |
Jun 27 2020 | n/a | n/a | US$110m |
Mar 28 2020 | n/a | n/a | US$103m |
Dec 28 2019 | US$2m | US$559k | US$101m |
Sep 28 2019 | n/a | n/a | US$102m |
Jun 29 2019 | n/a | n/a | US$109m |
Mar 30 2019 | n/a | n/a | US$121m |
Dec 29 2018 | US$2m | US$534k | US$126m |
Sep 29 2018 | n/a | n/a | US$88m |
Jun 30 2018 | n/a | n/a | US$81m |
Mar 31 2018 | n/a | n/a | US$70m |
Dec 30 2017 | US$1m | US$523k | US$63m |
Compensation vs Market: Jim's total compensation ($USD1.79M) is below average for companies of similar size in the US market ($USD3.31M).
Compensation vs Earnings: Jim's compensation has been consistent with company performance over the past year.
CEO
Jim Brown (54 yo)
7.3yrs
Tenure
US$1,793,140
Compensation
Mr. Jim Brown has been the President of USANA Health Sciences Inc. since November 2016 and served as its Chief Operating Officer since November 2013 until October 2019. He serves as Chief Executive Officer...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 6.8yrs | US$3.75m | 0.062% $ 575.0k | |
CEO & President | 7.3yrs | US$1.79m | no data | |
Chief Financial Officer | 6.8yrs | US$1.48m | 0.027% $ 248.7k | |
Chief Operating Officer | 4.4yrs | US$1.26m | no data | |
Chief Field Development Officer | 7.1yrs | US$1.18m | 0.041% $ 374.3k | |
Founder & Chairman Emeritus | 32.2yrs | no data | 40.97% $ 377.1m | |
Executive Director of Product Development & Technology | 11.3yrs | no data | no data | |
Chief Scientific Officer | 7.6yrs | no data | no data | |
Executive Director of Investor Relations & Business Development | no data | no data | no data | |
Chief Legal Officer | 5.7yrs | no data | no data | |
Chief Communications & Marketing Officer | 12.3yrs | US$946.07k | 0.020% $ 181.3k | |
Chief People Officer | 3.1yrs | US$637.78k | 0.047% $ 429.5k |
7.1yrs
Average Tenure
57.5yo
Average Age
Experienced Management: USNA's management team is seasoned and experienced (7.1 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Executive Chairman | 6.8yrs | US$3.75m | 0.062% $ 575.0k | |
Founder & Chairman Emeritus | 3.8yrs | no data | 40.97% $ 377.1m | |
Lead Independent Director | 15.5yrs | US$250.54k | no data | |
Independent Director | 5.3yrs | US$230.84k | 0.016% $ 150.1k | |
Independent Director | 4.4yrs | US$218.64k | 0.025% $ 227.8k | |
Member of Scientific Advisory Council | no data | no data | no data | |
Member of Scientific Advisory Council | no data | no data | no data | |
Chairperson of Scientific Advisory Council | 20.2yrs | no data | no data | |
Member of Scientific Advisory Council | no data | no data | no data | |
Member of Scientific Advisory Council | no data | no data | no data | |
Independent Director | 7.8yrs | US$233.84k | 0.014% $ 128.4k | |
Independent Director | 1.7yrs | US$118.10k | 0.012% $ 114.6k |
6.0yrs
Average Tenure
67yo
Average Age
Experienced Board: USNA's board of directors are considered experienced (6 years average tenure).